33799358|t|Corticospinal Tract and Related Grey Matter Morphometric Shape Analysis in ALS Phenotypes: A Fractal Dimension Study.
33799358|a|A pathological hallmark of amyotrophic lateral sclerosis (ALS) is corticospinal tract (CST) degeneration resulting in upper motor neuron (UMN) dysfunction. No quantitative test is available to easily assess UMN pathways. Brain neuroimaging in ALS promises to potentially change this through identifying biomarkers of UMN dysfunction that may accelerate diagnosis and track disease progression. Fractal dimension (FD) has successfully been used to quantify brain grey matter (GM) and white matter (WM) shape complexity in various neurological disorders. Therefore, we investigated CST and whole brain GM and WM morphometric changes using FD analyses in ALS patients with different phenotypes. We hypothesized that FD would detect differences between ALS patients and neurologic controls and even between the ALS subgroups. Neuroimaging was performed in neurologic controls (n = 14), and ALS patients (n = 75). ALS patients were assigned into four groups based on their clinical or radiographic phenotypes. FD values were estimated for brain WM and GM structures. Patients with ALS and frontotemporal dementia (ALS-FTD) showed significantly higher CST FD values and lower primary motor and sensory cortex GM FD values compared to other ALS groups. No other group of ALS patients revealed significant FD value changes when compared to neurologic controls or with other ALS patient groups. These findings support a more severe disease process in ALS-FTD patients compared to other ALS patient groups. FD value measures may be a sensitive index to evaluate GM and WM (including CST) degeneration in ALS patients.
33799358	75	78	ALS	Disease	MESH:D000690
33799358	145	174	amyotrophic lateral sclerosis	Disease	MESH:D000690
33799358	176	179	ALS	Disease	MESH:D000690
33799358	184	222	corticospinal tract (CST) degeneration	Disease	MESH:D009410
33799358	236	272	upper motor neuron (UMN) dysfunction	Disease	MESH:D016472
33799358	361	364	ALS	Disease	MESH:D000690
33799358	435	450	UMN dysfunction	Disease	MESH:D016472
33799358	647	669	neurological disorders	Disease	MESH:D009461
33799358	718	727	GM and WM	Disease	MESH:D056784
33799358	770	773	ALS	Disease	MESH:D000690
33799358	774	782	patients	Species	9606
33799358	867	870	ALS	Disease	MESH:D000690
33799358	871	879	patients	Species	9606
33799358	925	928	ALS	Disease	MESH:D000690
33799358	1004	1007	ALS	Disease	MESH:D000690
33799358	1008	1016	patients	Species	9606
33799358	1027	1030	ALS	Disease	MESH:D000690
33799358	1031	1039	patients	Species	9606
33799358	1180	1188	Patients	Species	9606
33799358	1194	1197	ALS	Disease	MESH:D000690
33799358	1202	1225	frontotemporal dementia	Disease	MESH:D057180
33799358	1227	1234	ALS-FTD	Disease	MESH:D000690
33799358	1352	1355	ALS	Disease	MESH:D000690
33799358	1382	1385	ALS	Disease	MESH:D000690
33799358	1386	1394	patients	Species	9606
33799358	1484	1487	ALS	Disease	MESH:D000690
33799358	1488	1495	patient	Species	9606
33799358	1560	1567	ALS-FTD	Disease	MESH:D000690
33799358	1568	1576	patients	Species	9606
33799358	1595	1598	ALS	Disease	MESH:D000690
33799358	1599	1606	patient	Species	9606
33799358	1670	1679	GM and WM	Disease	MESH:D056784
33799358	1712	1715	ALS	Disease	MESH:D000690
33799358	1716	1724	patients	Species	9606

